For BPC-157 specifically, the FDA reported limited and short human studies, a lack of adequate studies for several commonly used routes of administration, potential immunogenicity concerns, possible liver and clotting signals in animal studies, and three adverse-event reports, while noting that a cause could not be established
Our cutting-edge, evidence-based approach combines advanced, state-of-the-art medical technologies, treatment modalities, and research to provide our patients with optimal results in the treatment of dry eye disease, Meibomian gland dysfunction (MGD), blepharitis, and ocular rosacea
Reader, I did not inject myself with the peptides
Dichtl S, Haschka D, Nairz M, Seifert M, Volani C, Lutz O, et al
A typical gut-focused course is 48 weeks, followed by reassessment